| 今开：18.44 | 昨收：18.19 |
| 最高：18.7 | 最低：18.2769 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.158350632E9 |
起步龙耀路05-14 13:49
$Innoviva(INVA)$ 公布的Q1业绩，suldur 在美国定价 500一针，6小时一次，用5-9天，大概一个疗程是10000美金，去年Q4卖400万美金大概3-400患者，今年Q1 200万美金大概150-200患者，对应全美不到2万的发病数，属于正常发挥吧，要加速覆盖。
抗生素药物的特点是患者用药周期极短，每次做的都是新...查看全文
Innoviva(INVA)05-09 04:55
$Innoviva(INVA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-055832 Act: 34 Size: 11 MB 网页链接查看全文
Innoviva(INVA)04-30 18:05
$Innoviva(INVA)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001193125-24-123033 Act: 34 Size: 155 KB 网页链接查看全文
Innoviva(INVA)06-21 05:05
$Innoviva(INVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-073454 Size: 7 KB 网页链接查看全文
Innoviva(INVA)05-22 08:25
$Innoviva(INVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899140-24-000628 Size: 4 KB 网页链接查看全文
Innoviva(INVA)06-21 04:55
$Innoviva(INVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-073442 Size: 7 KB 网页链接查看全文
Innoviva(INVA)05-09 04:55
$Innoviva(INVA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-058747 Act: 34 Size: 327 KB 网页链接查看全文
Innoviva(INVA)05-22 08:15
$Innoviva(INVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899140-24-000627 Size: 4 KB 网页链接查看全文
Innoviva(INVA)06-21 05:05
$Innoviva(INVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-073449 Size: 7 KB 网页链接查看全文
Innoviva(INVA)05-09 18:15
$Innoviva(INVA)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-134533 Act: 34 Size: 2 MB 网页链接查看全文
Pharmayang2018-04-25 08:09
$Innoviva, Inc.(INVA)$ Trelegy Ellipta今天获批扩展适应症在COPD with airflow limitation or who have experienced an acute worsening of respiratory symptoms. 市场估计比以前大了50%。买点囤着。查看全文
H3llinger2018-03-24 08:09
Apparently $葛兰素史克(GSK)$ is no longer interested in acquiring Pfizer’s consumer healthcare business. It would make sense for GSK to buyout $Innoviva, Inc.(INVA)$ & $Theravance Biopharma, Inc. - Ordinary Shares(TBPH)$ ’s royalty interests in trelegy ellipta, since th...查看全文
医药魔方2017-09-20 10:30
GSK/Innoviva 9月18日宣布，FDA批准三联复方新药Trelegy Ellipta上市，用于慢性阻塞性肺病（COPD）患者的每日1次长期维持治疗。Trelegy Ellipta不适用于急性支气管痉挛和哮喘。
Trelegy Ellipta是将吸入性皮质类固醇（ICS）药物糠酸氟替卡松、长效β受体激动剂（LABA）维兰特罗、长效毒蕈碱拮...查看全文
$Innoviva(INVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-073444 Size: 7 KB 网页链接
$Innoviva(INVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-073447 Size: 7 KB 网页链接
$Innoviva(INVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-073449 Size: 7 KB 网页链接
$Innoviva(INVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-073454 Size: 7 KB 网页链接
$Innoviva(INVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-073456 Size: 7 KB 网页链接
$Innoviva(INVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-073442 Size: 7 KB 网页链接
$Innoviva(INVA)$ 8-K Current report, item 5.07 Accession Number: 0001104659-24-073416 Act: 34 Size: 206 KB 网页链接
$Innoviva(INVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899140-24-000628 Size: 4 KB 网页链接
$Innoviva(INVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899140-24-000627 Size: 4 KB 网页链接
$Innoviva(INVA)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000038777-24-000073 Act: 34 Size: 205 KB 网页链接